Select a dentist below from our skilled & talented team.
If you are looking for a way to save on your prescription costs, you may be wondering if a price reduction on Sildenafil citrate 100mg is possible. Sildenafil citrate is the active ingredient in Viagra, and is used to treat erectile dysfunction and pulmonary arterial hypertension. The patent for Viagra expires in 2020, which means that generic versions of the drug will become available. This could lead to a significant reduction in the cost of Sildenafil citrate.
In addition to the expiration of the Viagra patent, there are a number of other factors that could lead to a reduction in the price of Sildenafil citrate. For example, the FDA has recently approved a generic version of Viagra, which is made by Teva Pharmaceuticals. This could lead to increased competition in the market, which could drive down prices. In addition, the FDA has also approved a new use for Viagra, which is to treat erectile dysfunction in men who have undergone prostate surgery. This could lead to increased demand for the drug, and could also put downward pressure on prices.
If you are interested in getting a price reduction on Sildenafil citrate, you may want to talk to your doctor or pharmacist. They may be able to offer you a discount if you purchase the drug through their office. You may also want to check with your insurance company to see if they offer any discounts for Viagra. Finally, you can check online to see if any pharmacies are offering discounts on the drug.
During Life Sexual Activity And Potency Vary And Sometimes Can Drop. ED Medications Are Aimed To Solve Problems Associated With Various Erectile Dysfunctions Such As Impotence. Age Is Not The Only Factor Affecting Potency. Among The Negative Factors Are Frequent Stressful Situations, Variety Of Diseases, Bad Nutrition. ED Medications Are Aimed To Solve Problems Associated With Various Erectile Dysfunctions Such As Impotence. Treatment Of Erectile Dysfunction Can Be Successful And Manageable With Highly Effective Medications Like Viagra, Cialis And Levitra.
Kamagra |
Top avana |
Silvitra |
|
Male dosage |
Muscle pain |
Muscle or back pain |
Memory problems |
Buy with american express |
100mg 272 tablet $459.95 |
30mg + 50mg 120 tablet $479.95 |
100 + 20mg 20 tablet $89.95 |
Free samples |
Yes |
You need consultation |
You need consultation |
Can you overdose |
Nearby pharmacy |
Order online |
RX pharmacy |
Buy with amex |
50mg 92 tablet $149.95 |
30mg + 50mg 92 tablet $399.95 |
100 + 20mg 90 tablet $269.95 |
Kamagra is a medication used to treat erectile dysfunction (ED). It is a phosphodiesterase type 5 (PDE5) inhibitor. Kamagra increases blood flow to the penis, allowing more blood to enter the penis, resulting in an erection.
Kamagra is available as a tablet, oral jelly, and effervescent tablet. The recommended dose is 50 mg taken as needed, about 1 hour before sexual activity. The maximum recommended dose is 100 mg. Kamagra can be taken with or without food.
If you are taking Kamagra for the first time, it is important to start with the lowest dose and increase the dose only if necessary. Kamagra may not work as well if you take it with a high-fat meal.
Kamagra is generally well tolerated. The most common side effects are headache, flushing, and upset stomach. Kamagra is not recommended for use in children.
If you have any questions about Kamagra, please talk to your doctor or pharmacist.
Sildenafil citrate is a white to off-white crystalline powder with a solubility of 3.5 mg/mL in water and a molecular weight of 666.7. The mean apparent volume of distribution following oral administration is 105 L, indicating distribution into the tissues.
Sildenafil is rapidly absorbed. Maximum observed plasma concentrations are reached within 30 to 120 minutes (median 60 minutes) of oral dosing in the fasted state. When sildenafil is taken with a high-fat meal, the rate of absorption is reduced, with a mean delay in Tmax of 60 minutes and a mean reduction in Cmax of 29%. The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
Sildenafil and its major circulating N-desmethyl metabolite are both approximately 96% bound to plasma proteins. Protein binding is independent of total drug concentrations.
Metabolism and Excretion
Sildenafil is cleared predominantly by the CYP3A4 (major route) and CYP2C9 (minor route) hepatic microsomal isoenzymes. The major circulating metabolite results from N-desmethylation of sildenafil, and is itself further metabolized. This metabolite has a PDE selectivity profile similar to sildenafil and an in vitro potency for PDE5 approximately 50% of the parent drug. Plasma concentrations of this metabolite are approximately 40% of those seen for sildenafil, so that the metabolite accounts for about 20% of sildenafil's pharmacologic effects.
Excretion of sildenafil into human milk
There are no adequate and well-controlled studies of sildenafil in pregnant women.
Nursing Mothers
Because many drugs are excreted in human milk, caution should be exercised when sildenafil is administered to a nursing woman.
Pediatric Use
Safety and effectiveness of sildenafil in pediatric patients have not been established.
Geriatric Use
Of the total number of subjects in clinical trials of sildenafil, 18% were 65 years and older, while 2% were 75 years and older. No overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.
Renal Impairment
No dose adjustment is required for mild (CLcr=50–80 mL/min) and moderate (CLcr=30–49 mL/min) renal impairment. In volunteers with severe renal impairment (Clcr<30 mL/min), sildenafil clearance was reduced, resulting in higher plasma exposure of sildenafil (2.5-fold), increased maximum concentration (Cmax), and prolonged half-life (t1/2) of sildenafil. A starting dose of 25 mg should be considered in patients with severe renal impairment [see Dosage and Administration (2.5), Use in Specific Populations (8.7), and Clinical Pharmacology (12.3)].
Hepatic Impairment
In volunteers with hepatic impairment (Child-Pugh Class A and B), sildenafil clearance was reduced, resulting in higher plasma exposure of sildenafil (twofold), increased maximum concentration (Cmax), and prolonged half-life (t1/2) of sildenafil. A starting dose of 25 mg should be considered in patients with mild hepatic impairment [see Dosage and Administration (2.5), Use in Specific Populations (8.6), and Clinical Pharmacology (12.3)].
Sildenafil is not indicated for use in children.
Safety and effectiveness of sildenafil have not been established in pediatric patients.
In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
Sildenafil is rapidly absorbed. Maximum observed plasma concentrations are reached within 30 to 120 minutes (median 60 minutes) of oral dosing in the fasted state. When sildenafil is taken with a high-fat meal, the rate of absorption is reduced, with a mean delay in Tmax of 60 minutes and a mean reduction in Cmax of 29%. The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues.
Sildenafil and its major circulating N-desmethyl metabolite are both approximately 96% bound to plasma proteins. Protein binding is independent of total drug concentrations.
Metabolism and Excretion
Sildenafil is cleared predominantly by the CYP3A4 (major route) and CYP2C9 (minor route) hepatic microsomal isoenzymes. The major circulating metabolite results from N-desmethylation of sildenafil, and is itself further metabolized. This metabolite has a PDE selectivity profile similar to sildenafil and an in vitro potency for PDE5 approximately 50% of the parent drug. Plasma concentrations of this metabolite are approximately 40% of those seen for sildenafil, so that the metabolite accounts for about 20% of sildenafil's pharmacologic effects.
Excretion of sildenafil into human milk
There are no adequate and well-controlled studies of sildenafil in pregnant women.
Nursing Mothers
Because many drugs are excreted in human milk, caution should be exercised when sildenafil is administered to a nursing woman.
Pediatric Use
Safety and effectiveness of sildenafil in pediatric patients have not been established.
Geriatric Use
Of the total number of subjects in clinical trials of sildenafil, 18% were 65 years and older, while 2% were 75 years and older. No overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.
Renal Impairment
No dose adjustment is required for mild (CLcr=50–80 mL/min) and moderate (CLcr=30–49 mL/min) renal impairment. In volunteers with severe renal impairment (Clcr<30 mL/min), sildenafil clearance was reduced, resulting in higher plasma exposure of sildenafil (2.5-fold), increased maximum concentration (Cmax), and prolonged half-life (t1/2) of sildenafil. A starting dose of 25 mg should be considered in patients with severe renal impairment [see Dosage and Administration (2.5), Use in Specific Populations (8.7), and Clinical Pharmacology (12.3)].
Hepatic Impairment
In volunteers with hepatic impairment (Child-Pugh Class A and B), sildenafil clearance was reduced, resulting in higher plasma exposure of sildenafil (twofold), increased maximum concentration (Cmax), and prolonged half-life (t1/2) of sildenafil. A starting dose of 25 mg should be considered in patients with mild hepatic impairment [see Dosage and Administration (2.5), Use in Specific Populations (8.6), and Clinical Pharmacology (12.3)].
Sildenafil is not indicated for use in children.
Safety and effectiveness of sildenafil have not been established in pediatric patients.
In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
Kamagra 100mg is a popular medication used to treat erectile dysfunction (ED) in men. It is a generic version of the popular brand-name drug Viagra, and is available at a much lower price. Kamagra 100mg is a phosphodiesterase type 5 (PDE5) inhibitor, which works by increasing blood flow to the penis during sexual stimulation. This helps men achieve and maintain an erection.
Kamagra 100mg is available in several forms, including tablets, oral jelly, and effervescent tablets. The tablets are taken orally with water, while the jelly and effervescent tablets are dissolved in water before being taken. The recommended dose is 100mg, taken about 30 minutes before sexual activity. It is important to note that Kamagra 100mg should not be taken more than once per day.
Kamagra 100mg is a safe and effective medication for ED, and is available at a much lower price than Viagra. It is important to note that Kamagra 100mg is not a cure for ED, and it does not increase sexual desire. It is also important to discuss any potential side effects with a doctor before taking Kamagra 100mg. Common side effects include headaches, flushing, indigestion, nasal congestion, and dizziness.
Kamagra 100mg is a great option for those looking for a cost-effective treatment for ED. It is important to discuss any potential side effects with a doctor before taking Kamagra 100mg. With proper use, Kamagra 100mg can help men achieve and maintain an erection, allowing them to enjoy a more satisfying sexual experience.
Sildenafil citrate is a white to off-white crystalline powder with a solubility of 3.5 mg/mL in water and a molecular weight of 666.7. Sildenafil citrate is designated chemically as 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate and has the following structural formula:
Sildenafil citrate is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). Sildenafil citrate is also marketed as Viagra for erectile dysfunction.
Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%). The pharmacokinetics of sildenafil are dose-proportional over the recommended dose range. It is eliminated predominantly by hepatic metabolism (mainly CYP3A4) and is converted to an active metabolite with properties similar to the parent, sildenafil. Both sildenafil and the metabolite have terminal half-lives of about 4 hours.
Sildenafil citrate is a weak inhibitor of the CYP isoforms 1A2, 2C9, 2C19, 2D6, 2E1 and 3A4 (IC50 >150 μM). The inhibition of PDE5 by sildenafil citrate results in an increase in cGMP levels in the corpus cavernosum.
Sildenafil citrate at recommended doses has no effect in the absence of sexual stimulation. When sexual stimulation causes local release of NO, inhibition of PDE5 by sildenafil causes increased levels of cGMP in the corpus cavernosum, resulting in smooth muscle relaxation and inflow of blood to the corpus cavernosum. Sildenafil citrate at recommended doses has no effect on visual acuity or contrast sensitivity.
In clinical pharmacology studies, sildenafil was shown to potentiate the hypotensive effect of nitrates. This is thought to result from the combined effects of nitrates and sildenafil on the nitric oxide/cGMP pathway. In a study of healthy male volunteers, co-administration of the endothelin antagonist, bosentan, an inducer of CYP3A4, CYP2C9 and possibly of CYP2C19, at steady state (125 mg twice a day) with sildenafil at steady state (80 mg three times a day) resulted in 62% and 55% decreases in sildenafil AUC and Cmax, respectively. Strong inhibitors of CYP3A4 such as ketoconazole or itraconazole could reduce sildenafil clearance.
Sildenafil citrate is excreted as metabolites predominantly in the feces (about 80% of administered oral dose) and to a lesser extent in the urine (around 13% of the administered oral dose).
Sildenafil citrate is a white to off-white crystalline powder with a solubility of 3.5 mg/mL in water and a molecular weight of 666.7. Sildenafil citrate is designated chemically as 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate and has the following structural formula:
Sildenafil citrate is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). Sildenafil citrate is also marketed as Viagra for erectile dysfunction.
Sildenafil citrate is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (range 25-63%). The pharmacokinetics of sildenafil are dose-proportional over the recommended dose range. It is eliminated predominantly by hepatic metabolism (mainly CYP3A4) and is converted to an active metabolite with properties similar to the parent, sildenafil. Both sildenafil and the metabolite have terminal half-lives of about 4 hours.
Sildenafil citrate is a weak inhibitor of the CYP isoforms 1A2, 2C9, 2C19, 2D6, 2E1 and 3A4 (IC50 >150 μM). The inhibition of PDE5 by sildenafil citrate results in an increase in cGMP levels in the corpus cavernosum.
Sildenafil citrate at recommended doses has no effect in the absence of sexual stimulation. When sexual stimulation causes local release of NO, inhibition of PDE5 by sildenafil causes increased levels of cGMP in the corpus cavernosum, resulting in smooth muscle relaxation and inflow of blood to the corpus cavernosum. Sildenafil citrate at recommended doses has no effect on visual acuity or contrast sensitivity.
In clinical pharmacology studies, sildenafil was shown to potentiate the hypotensive effect of nitrates. This is thought to result from the combined effects of nitrates and sildenafil on the nitric oxide/cGMP pathway. In a study of healthy male volunteers, co-administration of the endothelin antagonist, bosentan, an inducer of CYP3A4, CYP2C9 and possibly of CYP2C19, at steady state (125 mg twice a day) with sildenafil at steady state (80 mg three times a day) resulted in 62% and 55% decreases in sildenafil AUC and Cmax, respectively. Strong inhibitors of CYP3A4 such as ketoconazole or itraconazole could reduce sildenafil clearance.
Sildenafil citrate is excreted as metabolites predominantly in the feces (about 80% of administered oral dose) and to a lesser extent in the urine (around 13% of the administered oral dose).
.Dr. Scott sees patients at the King of Prussia, Havertown (Broomall) and Ardmore offices.
Dr. Walley sees patients at the King of Prussia and Havertown (Broomall) offices.
Dr. Patel sees patients at the Ardmore and Havertown (Broomall) offices.
Bryan Ruda sees orthodontic patients at the King of Prussia and Havertown (Broomall) offices.
Dr. Durra sees patients at the King of Prussia, Chalfont (Highpoint) and Bethlehem offices.
Dr. Jess sees patients at the King of Prussia, Chalfont (Highpoint), Allentown and Bethlehem offices.
Dr. Mike sees patients at the Chalfont (Highpoint), Allentown and Bethlehem offices.
Dr. DeBarros sees patients at the King of Prussia and Ardmore offices.
Dr. Sheka sees patients at the Bethlehem office.
Dr. Moscow sees patients at the Havertown (Broomall) office.
Dr. Bauerle sees patients at the Ardmore, Broomall and King of Prussia offices.
Dr. Peck sees patients in the King of Prussia and Highpoint offices.
Dr. Marc sees patients at the King of Prussia, Ardmore, Pottstown, Allentown and Havertown (Broomall) offices.
Dr. DiGerolamo sees patients at the King of Prussia and Allentown offices.
Dr. Devin sees patients at our Allentown, PA office.
Dr Herrera sees patients at the King of Prussia, Pottstown, Chalfont (Highpoint) and Allentown offices. Dr Herrera is bilingual- she speaks English and Spanish.
You should clean and massage your baby's gums daily to help establish healthy gums and to aid in teething. Cleaning your child's teeth should begin when the first tooth is visible (at about six months) because teeth are susceptible to decay as soon as they appear in the mouth.
Read more tipsVisit our Adult Dentistry website to meet our dentists, view our services, and learn more about our patient information.
upper merion adult dentistry